Navigation Links
Pro-Dex, Inc. And AO Partners Group Jointly Announce Voting Results
Date:1/22/2013

IRVINE, Calif., Jan. 22, 2013 /PRNewswire/ -- PRO-DEX, INC. (Nasdaq: PDEX) and AO Partners Group jointly announced today the results of voting from the Company's Annual Meeting of Shareholders held on January 17, 2013.

(Logo: http://photos.prnewswire.com/prnh/20111025/LA93174LOGO-c)

In June 2012, AO Partners Group, whose members own approximately 22% of the Company's outstanding common stock, nominated a slate of three director nominees to run in opposition to the Company's slate of five director nominees, four of whom were incumbent members of the Company's Board.  At its January 17, 2013 Annual Meeting, shareholders of the Company elected AO's three director nominees, Nicholas J. Swenson , Raymond E. Cabillot and William J. Farrell III , along with two of the Company's nominees, incumbent Chairman William L. Healey and David C. Hovda , to fill the five seats on the Company's new Board of Directors.  Mr. Healey will be the only member of the current Board to continue onto the new Board.          

Michael J. Berthelot , the Company's President and Chief Executive Officer, commented, "We are pleased to have this behind us and we look forward to working with our new board.  Every member of our management team and each of our associates remain committed to designing, developing and manufacturing the best possible products for our customers and in doing so creating value for all of our stakeholders.  We thank our departing board members for their service to our Company and wish them well in the future."

'/>"/>

SOURCE Pro-Dex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pro-Dex, Inc. Announces Fiscal Second Quarter And Six-Month Results
2. Pro-Dex, Inc. Announces Fiscal 2013 First Quarter Results
3. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter And Full-Year Results
4. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast
5. Pro-Dex, Inc. Announces Update Conference Call and Webcast
6. Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results
7. Pro-Dex, Inc. Announces Fiscal 2012 Third Quarter Financial Results Conference Call and Webcast
8. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
9. Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation
10. KNODE & the University of Louisville Announce Partnership: New site links UofL experts to world
11. Producer Austin Chapman Reaches Millions with Inspiring Story on Hearing Loss; Launches Contest in Partnership with Phonak
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 21, 2014  Heated dialogue in recent months about ... cancer treatments to Gilead,s new hepatitis C drug Harvoni® ... world questioning what it means to put a price ... And while drug pricing is one of the ... both a general business and ethical standpoint – it ...
(Date:11/21/2014)... , Nov. 21, 2014 ... the European Medicines Agency (EMA) has granted ... company,s lead product candidate, for the treatment ... a rare, severely disabling genetic disease characterized ... swelling (flare-ups) and new abnormal bone formation. ...
(Date:11/21/2014)... , Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... , Chief Executive Officer, will be presenting at the 26 ... York Palace Hotel in New York . ... at 2:00 PM ET. In addition, Mr. Krakauer and ... for separate one-on-one meetings during the day. ...
Breaking Medicine Technology:"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3
... IRIDEX Corporation (NASDAQ: IRIX ) today announced that it ... after the market closes on Thursday, March 1, 2012. ... a conference call with the investment community at 5:00 ... 2012 to discuss the results of the quarter and ...
... Medical Corp.,s (Nasdaq Market: ESMC) subsidiary,  Sonomed Escalon™ announced ... AXIS™ Image Management System at the recent World Ophthalmology ... Matthew Carnevale, Chief Technical Officer, stated that ... ophthalmic diagnostic imaging management, and provides an entirely new ...
Cached Medicine Technology:Sonomed Escalon™ Announces Release of AXIS™ iPad App 2Sonomed Escalon™ Announces Release of AXIS™ iPad App 3
(Date:11/22/2014)... Steven Reinberg HealthDay Reporter ... outcomes are better when patients are treated in an ambulance ... drugs, German researchers report. The sooner patients get the ... the outcome after a stroke, the researchers noted. For the ... first hour after stroke symptoms start, the researchers said. ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 CRN International, ... veteran radio industry sales professional to its award-winning team. ... 30 years of leadership and sales experience to CRN. ... assume the title of Director of Strategy and Development, ... Robert O’Mara. , Heinemann will handle a wide range ...
(Date:11/21/2014)... -- Seeking to make it tougher for people to ... on Thursday approved a new hydrocodone tablet that,s designed ... by the brand name Vicodin -- is a powerful ... in dangerous addictions across the United States. The ... is an extended-release tablet to treat pain severe enough ...
(Date:11/21/2014)... (HealthDay News) -- Scientists say they,ve mapped the genome -- ... British man,s brain, in hopes it might help others with ... the journal Genome Biology , the tapeworm was removed ... ethnicity. "This infection is so rare worldwide and completely ... ... until the worm was pulled out from the brain," ...
(Date:11/21/2014)... Mass. (PRWEB) November 21, 2014 Center ... free workshops titled “Massachusetts Insurance Funding for Autism Workshops” ... (ASD) navigate their way through the insurance coverage process. ... under Massachusetts law and the most effective ways to ... Thursday, Dec. 4 from 6-8:00 p.m. at 331 Montvale ...
Breaking Medicine News(10 mins):Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 2Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 3Health News:Radio Industry Veteran Joins CRN International’s Sales Organization in Detroit 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 3Health News:Ick! Tapeworm Infecting Man's Brain Yields Genetic Secrets 2Health News:Center for Autism and Related Disorders to Host Massachusetts Autism Insurance Workshops for Parents 2
... A new study shows there is some truth in the ... the brain active. It is long been believed that mental ... the Rush Alzheimer's Disease Centre in the US now reveal ... ongoing Religious Orders Study, involving the cognitive health of older ...
... research has established that a decreased white blood ... aggressive periodontitis.The scientists showed that at six weeks of ... of their alveolar bone whereas the normal mice had ... which anchors teeth in place, is an indication of ...
... said that older hospital patients with delirium run a ... condition. Researchers suggested there's a need for research to ... to investigate interventions that can be made after discharge ... study covered 361 patients aged 65 or older, of ...
... Better health may be only a dash and sprinkel ... found that herbs, in addition to making food tastier, ... potential anticancer benefits when supplementing a balanced diet.Herbs have ... including garlic, the researchers say. Their findings appear in ...
... was found using new technology which helps prevent stroke. One ... by ultrasound, at any blockages in the carotid arteries that ... the US have pioneered the use of a portable device, ... 20 people, this was used to take two different images ...
... measles, mumps and rubella is in short supply. The ... with shortfalls caused by production problems, fewer drugmakers// and ... ,The situation is so bad that 8 of the ... tetanus, diphtheria and a pneumococcal vaccine used to prevent ...
Cached Medicine News:Health News:Herbs: rich soure of antioxidants 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: